IUH Recruitment Policy Training

The new IUH Recruitment Policy Training Materials and Documents are now available on our website in the Private Documents section. To access the Private Documents section of our website please log in using your CAS Credentials and then click on the Private Documents button to enter the Private Documents section of our site.

Also, if you would like to view the video of the IUH Recruitment Policy Training Presentation then there are instructions posted in the Private Documents section.

For assistance gaining access please contact our main mailbox at cto@iu.edu

Indiana University to provide paid parental leave for staff

Effective July 1, IU will begin offering fully paid parental leave for all staff employees of the university.

 

Read more

Eskenazi Health: New Medical Director of Smith Level I Shock Trauma Center

Indianapolis, Dec. 19, 2016 – Eskenazi Health announces that Ben L. Zarzaur Jr., M.D., MPH, has been appointed to the position of medical director of the Smith Level I Shock Trauma Center at Eskenazi Health. He is also currently an associate professor, director of the Center for Outcomes Research in Surgery and vice-chair for Clinical Research in the Department of Surgery at the Indiana University School of Medicine.

“Dr. Zarzaur is a highly credentialed leader in his field and poised to make a tremendous contribution here at Eskenazi Health,” said Dr. Lisa E. Harris, chief executive officer at Eskenazi Health. “We’re all very pleased to welcome him to our team.”

Prior to joining the IU School of Medicine in 2014, Dr. Zarzaur was an associate professor of Surgery at the University of Tennessee Health Science Center in Memphis, Tennessee where he worked at one of the busiest trauma centers in the United States. Dr. Zarzaur started his professional career as an assistant professor of Surgery at the University of North Carolina – Chapel Hill in 2004.  While at Chapel Hill, he completed a Masters in Public Health in Epidemiology at the School of Public Health at the University of North Carolina. In 2006, he moved to the University of Tennessee Health Science Center as an assistant professor of Surgery where he rose through the academic ranks to obtain tenure and the rank of associate professor. While in Memphis, Dr. Zarzaur also served as an assistant professor in the Department of Preventive Medicine and he as an adjunct professor at the University of Memphis School of Public Health.

Originally Published by Eskenazi Health: Read full article here.

Washington Post: Obama Signs 21st Century Cures Act

Paying tribute to both bipartisanship and his vice president — who was galvanized by his own son’s death to change the way the United States combats cancer — President Obama signed legislation Tuesday that aims to increase funding for medical research, speed the development and approval of experimental treatments and overhaul federal policy on mental health care.

“We are bringing to reality the possibility of new breakthroughs to some of the greatest health-care challenges of our time,” Obama said. “It is wonderful to see how well Democrats and Republicans in the closing day of this Congress came together around a common cause. And I think it indicates the power of this issue and how deeply it touches every family across America.”

The 21st Century Cures Act had wide bipartisan support and has been held up as an example of what Congress can accomplish by working together. After a previous version of the bill stalled in the Senate for more than a year, a new version — cheered by the drug and medical device industry, patient advocates and universities — made a swift passage through the lame-duck session.

The measure’s critics — mainly consumer watchdog groups and health policy experts — have argued that the popular funding provisions mask a worrisome loosening of regulations at the Food and Drug Administration that could put patients at risk.

The bill contains several provisions that the White House has championed, including $1 billion for opioid abuse prevention and $4.8 billion for biomedical research funding, including Obama’s Precision Medicine initiative and the BRAIN initiative. A hefty chunk of that funding — $1.8 billion — is dedicated to cancer research, a part of the bill that was renamed the “Beau Biden Cancer Moonshot” in honor of the vice president’s late son, who died of a brain tumor. The bill also aims to strengthen mental health services and access.

Originally Published in the Washington Post: Read full article here.